BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 34470475)

  • 21. Plasminogen activator inhibitor-1, thrombin-antithrombin, and prothrombin fragment F1+2 have higher diagnostic values than D-dimer for venous thromboembolism after TKA.
    Yang Y; Feng G; Yan J; Wu L; Wang F; Ding D; Wang H; Jin Q
    Clin Appl Thromb Hemost; 2022; 28():10760296221097383. PubMed ID: 35535394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review.
    Eljilany I; Elzouki AN
    Vasc Health Risk Manag; 2020; 16():455-462. PubMed ID: 33223833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS).
    Ay C; Simanek R; Vormittag R; Dunkler D; Alguel G; Koder S; Kornek G; Marosi C; Wagner O; Zielinski C; Pabinger I
    Blood; 2008 Oct; 112(7):2703-8. PubMed ID: 18539899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimating risk of venous thromboembolism in patients with cancer in the presence of competing mortality.
    Ay C; Posch F; Kaider A; Zielinski C; Pabinger I
    J Thromb Haemost; 2015 Mar; 13(3):390-7. PubMed ID: 25529107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia.
    Giordano P; Molinari AC; Del Vecchio GC; Saracco P; Russo G; Altomare M; Perutelli P; Crescenzio N; Santoro N; Marchetti M; De Mattia D; Falanga A
    Am J Hematol; 2010 May; 85(5):325-30. PubMed ID: 20425794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombosis risk and survival in cancer patients with elevated C-reactive protein.
    Kanz R; Vukovich T; Vormittag R; Dunkler D; Ay C; Thaler J; Haselböck J; Scheithauer W; Zielinski C; Pabinger I
    J Thromb Haemost; 2011 Jan; 9(1):57-63. PubMed ID: 20874781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for venous thromboembolism in cancer: novel findings from the Vienna Cancer and Thrombosis Study (CATS).
    Königsbrügge O; Pabinger I; Ay C
    Thromb Res; 2014 May; 133 Suppl 2():S39-43. PubMed ID: 24862144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
    Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
    Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statin therapy and levels of hemostatic factors in a healthy population: the Multi-Ethnic Study of Atherosclerosis.
    Adams NB; Lutsey PL; Folsom AR; Herrington DH; Sibley CT; Zakai NA; Ades S; Burke GL; Cushman M
    J Thromb Haemost; 2013 Jun; 11(6):1078-84. PubMed ID: 23565981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer.
    Claussen C; Rausch AV; Lezius S; Amirkhosravi A; Davila M; Francis JL; Hisada YM; Mackman N; Bokemeyer C; Schmalfeldt B; Mahner S; Langer F
    Thromb Res; 2016 May; 141():39-48. PubMed ID: 26967531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Estimation of venous thromboembolism risk with thrombotic biomarkers in cancer patients].
    Jianlong M; Diansheng Z; Jing R
    Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):283-9. PubMed ID: 26462893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating Extracellular Vesicle Tissue Factor Activity During Orthohantavirus Infection Is Associated With Intravascular Coagulation.
    Schmedes CM; Grover SP; Hisada YM; Goeijenbier M; Hultdin J; Nilsson S; Thunberg T; Ahlm C; Mackman N; Fors Connolly AM
    J Infect Dis; 2020 Sep; 222(8):1392-1399. PubMed ID: 31722433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Children with Provoked Venous Thromboembolism, Increasing Plasma Coagulability during the First 3 Months Postdiagnosis is Prognostic of Recurrence.
    Betensky M; Mueller MG; Amankwah EK; Goldenberg NA
    Thromb Haemost; 2020 May; 120(5):823-831. PubMed ID: 32369853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential biomarker profiles between unprovoked venous thromboembolism and cancer.
    Sánchez-López V; Gao L; Ferrer-Galván M; Arellano-Orden E; Elías-Hernández T; Jara-Palomares L; Asensio-Cruz MI; Castro-Pérez MJ; Rodríguez-Martorell FJ; Lobo-Beristain JL; Ballaz-Quincoces A; López-Campos JL; Vila-Liante V; Otero-Candelera R
    Ann Med; 2020 Sep; 52(6):310-320. PubMed ID: 32634035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes.
    Frere C; Bournet B; Gourgou S; Fraisse J; Canivet C; Connors JM; Buscail L; Farge D;
    Gastroenterology; 2020 Apr; 158(5):1346-1358.e4. PubMed ID: 31843588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS).
    Simanek R; Vormittag R; Ay C; Alguel G; Dunkler D; Schwarzinger I; Steger G; Jaeger U; Zielinski C; Pabinger I
    J Thromb Haemost; 2010 Jan; 8(1):114-20. PubMed ID: 19889150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of complete blood count parameters, d-dimer, and soluble P-selectin with risk of arterial thromboembolism in patients with cancer.
    Grilz E; Marosi C; Königsbrügge O; Riedl J; Posch F; Lamm W; Lang IM; Pabinger I; Ay C
    J Thromb Haemost; 2019 Aug; 17(8):1335-1344. PubMed ID: 31099477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations between venous thromboembolism onset, D-dimer, and soluble fibrin monomer complex after total knee arthroplasty.
    Mitani G; Takagaki T; Hamahashi K; Serigano K; Nakamura Y; Sato M; Mochida J
    J Orthop Surg Res; 2015 Nov; 10():172. PubMed ID: 26555394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased platelet reactivity in patients with cancer is associated with high risk of venous thromboembolism and poor prognosis.
    Riedl J; Kaider A; Marosi C; Prager GW; Eichelberger B; Assinger A; Pabinger I; Panzer S; Ay C
    Thromb Haemost; 2017 Jan; 117(1):90-98. PubMed ID: 27761580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) study.
    Lutsey PL; Folsom AR; Heckbert SR; Cushman M
    J Thromb Haemost; 2009 Oct; 7(10):1639-48. PubMed ID: 19656279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.